Related references
Note: Only part of the references are listed.Suppression of the nuclear transporter-KPN beta 1 expression inhibits tumor proliferation in hepatocellular carcinoma
Linlin Yang et al.
MEDICAL ONCOLOGY (2015)
Prevalence and Clinical Implications of Cyclin D1 Expression in Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Immunochemotherapy
Chi Young Ok et al.
CANCER (2014)
Inhibition of the nuclear transporter, Kpnβ1, results in prolonged mitotic arrest and activation of the intrinsic apoptotic pathway in cervical cancer cells
Liselotte Angus et al.
CARCINOGENESIS (2014)
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
Lina Odqvist et al.
MODERN PATHOLOGY (2014)
Expression of small glutamine-rich TPR-containing protein A (SGTA) in Non- Hodgkin's Lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR)
Yuchan Wang et al.
LEUKEMIA RESEARCH (2014)
Nuclear import of SAMHD1 is mediated by a classical karyopherin α/β1 dependent pathway and confers sensitivity to VpxMAC induced ubiquitination and proteasomal degradation
Torsten Schaller et al.
RETROVIROLOGY (2014)
Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer
Sanne R. Martens-de Kemp et al.
CLINICAL CANCER RESEARCH (2013)
The Nuclear Import Receptor Kpnβ1 and Its Potential as an AntiCancer Therapeutic Target
Pauline J. van der Watt et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2013)
MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
Haitao Bai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Pathogenesis of Human B Cell Lymphomas
Arthur L. Shaffer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation
Tao Tao et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
Expression of Spy1 protein in human Non-Hodgkin's Lymphomas is correlated with phosphorylation of p27Kip1 on Thr187 and cell proliferation
Qinglei Hang et al.
MEDICAL ONCOLOGY (2012)
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
Marek Mraz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
Pauline J. Van der Watt et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-Hodgkin's lymphoma cells
T. Lwin et al.
LEUKEMIA (2007)
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?
AO de Graaf et al.
LEUKEMIA (2004)
Karyopherins: from nuclear-transport mediators to nuclear-function regulators
N Mosammaparast et al.
TRENDS IN CELL BIOLOGY (2004)
The inhibitors of apoptosis: there is more to life than Bcl2
P Liston et al.
ONCOGENE (2003)
Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells
TH Landowski et al.
ONCOGENE (2003)
Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia:: analysis of NF-κB/Rel-regulated inhibitors of apoptosis
G Munzert et al.
BLOOD (2002)
Share Paper
